Explore UAB

Gastroenterology & Hepatology

Forging the future of gastroenterology and hepatology

The UAB Division of Gastroenterology and Hepatology is an integral part of one of the nation's largest health systems. Nationally known for our compassionate care, cutting-edge research, and comprehensive training programs, we're dedicated to delivering the most advanced care.

OUR PROGRAMS

Preparing the next generation of physicians and scientists

We're dedicated to nurturing and guiding the future generation of physicians and physician-scientists, recognizing that our trainees are the cornerstone of our nation's healthcare system.

OUR PEOPLE

Home to leading experts and distinguished scholars

Our faculty, staff, and trainees play an exceptionally critical role in shaping the future of healthcare through their expertise in education, research, and clinical practice, driving innovation and excellence.

Latest Headlines

  • UAB receives renewed funding for colorectal cancer screening project
    Nov 18, 2024
  • UAB celebrates milestone with 3,000 adult liver transplants
    Sep 26, 2024
  • UAB Hospital continues to be the best hospital in Alabama, Birmingham metro, according to U.S. News & World Report
    Jul 16, 2024
  • UAB to offer free colonoscopy screenings to under- and uninsured for second consecutive year
    May 21, 2024


Research Associate Professor in Microbiology
Phone:  
934-4215
E-mail: 
zinam@uab.edu

moldoveanu

Dr. Moldoveanu received her M.S. and Ph.D. degrees in biochemistry from the University of Bucharest, Romania.  She came to UAB as a postdoctoral fellow in mucosal immunology in Dr. Jiri Mestecky’s laboratory and joined the Department of Microbiology faculty in 1988.  In 1998 she did sabbatical work with Dr. Mogens Kilian, Director of the Institute of Immunology and Microbiology at the University of Aarhus, Denmark.

Dr. Moldoveanu’s work in mucosal immunology focuses on vaccine development, IgA synthesis and transport, IgA receptor expression, and the role of innate factors in immune complex disease.  She has pioneered studies of alternative routes of mucosal and systemic vaccine administration in animal models (mice, monkeys) and in humans. She and her colleagues are currently involved in the evaluation of immune responses to vaccine antigens administered with systemic or mucosal adjuvants, as well as vaccine antigens administered in biodegradable microspheres, liposomes, block polymers, encapsidated poliovirus replicons or encoded in recombinant vaccinia- and baculo- viruses. She was also evaluating the humoral and cellular responses induced by HIV-1 candidate vaccines in human volunteers enrolled in Phase I trials.  Currently, besides studies on the defective glycosylation of IgA pertinent to IgA nephropathy, Dr. Moldoveanu is investigating immunization parameters, including type of antigen, adjuvants and route of administration, for effective induction of mucosal and systemic humoral responses and tolerance in human volunteers.  She is also evaluating the role of oral epithelial cells in HIV-1  transmission.

Selected Publications

  1. Moldoveanu, Z., Russell, M.W., Wu, H.Y., Huang, W.Q., Compans, R.W. and Mestecky, J.  Compartmentalization within the mucosal immune system.  Adv. Exp. Med. Biol. 371:97-101, 1995.
  2. Moldoveanu, Z., Clements, M.L., Prince, S.J., Murphy, B.R. and Mestecky, J.  Human immune responses to influenza virus vaccine administered by mucosal or systemic routes. Vaccine 11:1006-1012, 1995.
  3. Moldoveanu, Z., Porter, D.C., Lu, A.L., McPhearson, S. and Morrow, C.D.  Immune Responses Induced by Administration of Encapsidated Poliovirus Replicons which Express HIV-1 gag and Envelope Proteins. Vaccine  13:1013-1022, 1995.
  4. Moldoveanu, Z., Love-Homan, L., Huang, W.Q. and Krieg, A.  CpG DNA, a novel adjuvant for systemic and mucosal immunization with influenza virus. Vaccine  16:1216-1224, 1998.
  5. Moldoveanu, Z., Vzorov, A.N., Huang, WQ., Mestecky, J. and Compans, R.W.  Induction of immune responses to SIV antigens by mucosally administered vaccines. AIDS Res. Human Retrovir.15:1469-1476, 1999.
  6. Lambert, J.S., Keefer, M., Mulligan, M.J., Schwartz, D., Mestecky, J., Weinhold, K., Smith, C., Hsieh, R., Moldoveanu, Z., Fast, P., Forrest B. and Koff, W.  A Phase I Safety and Immunogenicity Trial of UBI® Microparticulate Monovalent HIV-1 MN Oral Peptide Immunogen with Parenteral Boost in HIV-1 Seronegative Human Subjects. Vaccine 19: 3033-3042, 2001.
  7. Mestecky, J., Jackson, S., Moldoveanu, Z., Nesbit, L.R., Kulhavy, R., Prince, S., Sabbaj, S., Mulligan, M.J., Weiss, H. and Goepfert, P.A.  Paucity of Antigen-Specific IgA Responses in Sera and External Secretions of HIV-1-Infected Individuals. AIDS Res. Human Retrovir. 20:972-88, 2004.
  8. Wright, P.F., Mestecky, J., McElrath, M.J., Keefer, M.C., Gorse, G.J., Goepfert, P.A., Moldoveanu, Z., Schwartz, D., Spearman, P.W., El Habib, R., Spring, M.D., Zhu, Y., Smith, C., Flores, J. and Weinhold, K.J. National Institutes of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein. J. Infect. Dis. 189:1221-31, 2004.
  9. Moldoveanu, Z., Oliver, F., Mestecky, J. and Elson, C.O.  Oral Tolerance in Humans: Failure to Suppress an Existing Immune Response by Oral Antigen Administration. Ann. N.Y. Acad. Sci. 1029:299-309, 2005.
  10. Moldoveanu, Z. and Fujihashi, K. Collection and Processing of External Secretions and Tissues of Mouse Origin In: Mucosal Immunology, 3rd Ed. Mestecky, J., Bienenstock, J., Lamm, M.E., Mayer, L., McGhee, J.R. and Stober, W., Eds. pp. 1841-1851, Elsevier Academic Press, Amsterdam, 2005.